An innovative transdermal delivery base for the rapid delivery of Cannabinoid isolates in acute pain management caused by sport injuries. It is also an ideal transdermal delivery base for Cannabinoids in managing breakthrough pain with the advantage of reducing the frequency of systemic use of opioid analgesics and NSAIDS. The foam is generated by unique foam activating packaging.
An innovative transdermal delivery base for the rapid delivery of Cannabinoid isolates in acute pain management caused by sport injuries. It is also an ideal transdermal delivery base for Cannabinoids in managing breakthrough pain with the advantage of reducing the frequency of systemic use of opioid analgesics and NSAIDS. The foam is generated by unique foam activating packaging. The foam dosage form makes topical application of Cannabinoids easy to the difficult to treat areas such as a hairy skin or the scalp.
Rapid release of Cannabinoids
Light & non-greasy
Ideal for application on difficult to treat area such as a hairy skin and the scalp
Eczema & Psoriasis
|Cannabinoid Isolates||%||Other Ingredients||%||Other Ingredients||%|
|CBC- Cannabichromene||1-5%||Menthol||2%||Methyl Salicylate||5%|
|CBG- Cannabigerol||1-5%||Vitamin C||2%||Melatonin||0.10%|
Speciefic Gravity: 1 – 1.05
Dosage form: Liquid
Compatible wetting agents: Ethoxy diglycol, Glycerin, Propylene Glycol & Water
Sizes available: 500 ml
SUGGESTED MIXING PROCESS
1. If the added ingredient is in powder form levigate the powder with suggested solvent prior to incorporating into Cannabase Foam Base.
2. Add Foam Base by geometric method to the mixture and mix well until homegenous.
3. Package in foam bottle.
Disclaimer: Transderma Pharmaceuticals Inc. has provided the formula and instructions above as a model for educational purposes only on the basis of recognized compendia and texts or references. The material provided is intended only for information purposes to pharmacists and medical team(s). Transderma Pharmaceuticals Inc. takes no responsibility for the validity or accuracy of this information or for its safety or effectiveness, nor for any use thereof, which is at the sole risk of the licensed pharmacist prescribing physician and health care provider/practitioner. Adjustments may be needed to meet specific patient needs and in accordance with a licensed prescriber’s prescription. The pharmacist must employ appropriate tests to determine the stability of this suggested formula. Transderma Pharmaceuticals Inc., its owners, officers, agents, contractors, affiliates and employees cannot be held liable to any person or entity concerning claims, loss or damage caused by, or alleged to be caused by, directly or indirectly, the use or misuse of the information contained in this suggested formula. In all cases, it is the responsibility of the licensed pharmacist to know the law, to compound any finished product and to dispense these products in accordance with Health Canada and FDA guidelines and appropriate Provincial Drug Schedules and Provincial or Territorial Pharmacy Practice Standards.
Toll Free: 1.800.663.1002
Xenex has been supplying the highest quality products, delivered by qualified professionals to the Canadian compounding profession for over 30 years. Xenex focuses on the compounding pharmacist and has built a valuable set of support services to provide the pharmacist with education, formulation support and competitively priced product, delivered by a knowledgeable sales and customer services team.